Lecture 25: Insulin Therapy Flashcards

1
Q

Insulin biosynthesis

A

-rDNA
-genetic code for human proinsulin inserted into plasmid of E. coli or bacteria/yeast to produce human proinsulin
-connecting peptide cleaved
-end product identical to human insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Physical and chemical properties fo insulin

A

-Lispro, Aspart, Glulisine, Regular insulin approved IV
-regular insulin used as IV formulation bc other ones are expensive and not even better
-NPH is suspension
-glargine and degludac are solutions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IV insulin

A

-REGULAR
-can use LAG but more expensive not worth it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

insulin suspension

A

NPH

-cloudy solutions
-DO NOT give as IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

insulin solutions

A

-glargine
-degludec

-clear solutions
-do NOT give as IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Insulin uses

A

-type 1 and 2 diabetes
-hyperkalemia
-type 2 diabetes in combo w noninsulin agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

insulin use in type 1 and 2 diabetes

A

-high fasting glucose levels > 280-300
-pt w ketoacidosis
-gestational diabetes
-whatever clinician says

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ultra short acting insulins

A

-Lispro (Humalog)
-Aspart (Novolog)
-Glulisine (Apidra)

-10-20 min onset
-dose after eating
-last 3-5 hours
-compatible when mixed w NPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Short acting insulin

A

-Regular (Humulin R)

-take 30 min before meals

-30-60 min onset
-5-8h duration
-compatible w NPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

-intermediate acting insulin

A

-NPH (humulin N)
-2-4h onset
-8-12h duration
-peak 4-10 hours dont have to give lunch dose
-can combo w lispro, aspart, gluilisince, regular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Long acting insulin

A

-Glargine (Lantus)
-2-4h onset
-20-24h duration
-no peak
-no combo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ultra long acting insulin

A

-Degludec (Tresiba)
-onset 1h
-24-48h duration
-no peak
-no combo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Insulin pre mixtures (short+long)

A

-NPH/regular mix 70/30 (Humulin 70/30 or Novolin 70/30)
-75% NPH (lispro instead of H) / 25% lispro (humalog 75/25) (or 50/50)
-70% aspart suspension / 30% aspart (Novolog 70/30)
-Degludec/aspart (Ryzodeg 70/30)

-add protamine to short acting to make last longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Concentrated insulins

A

-Regular U500 (weight gain)
-Degludec U200
-Toujeo U300
-Lispro U200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Factors altering insulin action

A

-route of admin
-site of inj
-temp
-exercise/massage
-mixtures
-dose
-compliance
-pt errors
-irregular diet/exercise
-renal function
-stress
-drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Site of injection

A

-stomach fastest
-butt and thighs slowest

-dont change the site for same meals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Temp effect

A

-heat increases absortpion and action

-outside heat
-heat from exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Exercise effect

A

-inc absorption and action
-less insulin on exercise days
-impacts injection site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Prep/mixture effect

A

-short-acting effect may be LOST is mixed incorrectly or left too long

-U-500 vs U 100 regular

20
Q

Dose effect

A

-smaller dose are absorbed more RAPIDLY

21
Q

Renal function effect

A

-dec insulin clearance
=inc insulin action
-15-20% of insulin metabolized by kidneys

22
Q

Stress effect

A

-inc insulin clearance

23
Q

INsulin stability

A

-vials at room temp: 28 days
-refrigerate vials/pens not in use (NO FREEZE)
-opened: discard after 28 days max
-prefilled syringes (non-mixes): 28 days cold, 10-28 days room temp

24
Q

Mixture stability: Regular/NPH

A

-stable 7 days in fridge
-always draw up short-acting fast

25
Mix stability: L/A/G + NPH
-give immediately
26
Mix stability: Degludec or Glargine with any other insulin
-NEVER -NOT COMPATIBLE
27
Complications of insulin therapy
-HYPOglycemia -weight gain -lipohypertrophy -lipoatrophy -allergic reactions
28
Hypoglycemia causes
-inc insulin dosage -dec caloric intake -inc muscle utilization -excess alcohol
29
Classification hypoglcemia
-Level 1: glucose <70 -2: <54 3: severe event w mental/physical impairment needing another peson for recovery
30
Low blood sugar symptoms
-shaking -sweating -anxious -dizziness -hunger -inc HR -vision -fatigue -HA -irritable -lots of sx gonna be masked by beta blockers
31
Hypoglycemia tx
-Rule of 15s -15g carb (30g if BG<50) -wait 15 min and check BG -if not >70 mg/dL, repeat -follow w complex carb (30g) if a meal is not planned within one hour -glucagon for sever
32
15g fact acting sugars
-4-5oz OJ -4-6oz cola (half can) -5-6 lifesavers -4 tsp sugar -1 T honey -glucose tabs/gel
33
Glucagon
-use for pt w severe hypoglycemia -IN, SQ, IM, IV -Baqsimi inhalation 3mg -Glucagen injection 1mg -Zegalogue injection 0.6mg
34
Lipohypertrophy
-repeated inj into same site -tumerous-like fat pads
35
Lipoatrophy
-concavities caused by destruction of fat from immune response
36
Advantages of ultra short
-dec postprandial hypoglycemia -better lowering of BG -less risk of hypoglycemia -better flexibility
37
Disadvantages of ultra-shorts
-risk of hypoglycemia if no meal right after dose -need to use w long acting insulin -must use immediately after mixing -hyperglycemia may occur faster is insulin delivery interuppted
38
Advantages of long acting
-24+ hour coverage w constant absorption -good for pt w nocturnal hyperglycemia
39
Disadvantages of long acting
-risk of cancer? -can NOT be mixed w other insulin
40
Glargine vs degludec
-degludec less hypoglycemia risk -more expensive maybe
41
Coverting U-100 insulins
-if pt changes from qd NPH to long acting, keep same dose -if from BID NPH, dec dose by 20%
42
Coverting U-100 to concentrated insulins
-if pt change from BID NPH to U-300 glargine, dec dose by 20% -1:1 conversion between daily glargine or detemir to daily glargine (Toujeo) may need an inc dose over time -1:1 conversion between basal insulin and U-200 insulin degludec (Tresiba) -1:1 between lispro U-100 to U-200 -U-100 to U-500 maybe 20% dec depending on A1c (replaces basal and bolus insulin types)
43
Conversion to U-500
A1c < 8%: dec daily dose 10-20% A1c = 8-10%: same A1c >10: inc dose 10-20% -more at breakfast bc it hangs out longer
44
If daily dose 150-300 units conversion to U500
-BID 60% before breakfast, 40% dinner -TID: 40/30/30
45
If TDD 300-600 units conversion to U500
-change to TID -consider 10% dose at bedtime for 4th injection
46
If TDD>600 conversion to U500
30/30/30/10